NDC properties for NDC 9 0143-9292
NDC item 00143929201
| NDC 9 | 0143-9292 |
|---|---|
| NDC 10 | 0143-9292-01 |
| NDC Item | 00143929201 |
| packaging | 1 VIAL in 1 BOX, UNIT-DOSE (0143-9292-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA211755 |
| FDA SPL set id | 732107 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-09-29 |
| Marketing status | ACTIVE |
NDC item 43598017111
| NDC 9 | 43598-171 |
|---|---|
| NDC 10 | 43598-171-11 |
| NDC Item | 43598017111 |
| packaging | 1 VIAL in 1 CARTON (43598-171-11) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA214222 |
| FDA SPL set id | 793662 |
| Labeler | Dr.Reddy's Laboratories Inc., |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-11-01 |
| Marketing status | ACTIVE |
NDC item 65219002920
| NDC 9 | 65219-029 |
|---|---|
| NDC 10 | 65219-029-20 |
| NDC Item | 65219002920 |
| packaging | 1 VIAL in 1 CARTON (65219-029-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA214222 |
| FDA SPL set id | 632402 |
| Labeler | Fresenius Kabi USA, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-04-11 |
| Marketing status | ACTIVE |
NDC item 68083050301
| NDC 9 | 68083-503 |
|---|---|
| NDC 10 | 68083-503-01 |
| NDC Item | 68083050301 |
| packaging | 1 VIAL in 1 CARTON (68083-503-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| ANDA | ANDA214222 |
| FDA SPL set id | 609541 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-01-03 |
| Marketing status | ACTIVE |
NDC item 69539012401
| NDC 9 | 69539-124 |
|---|---|
| NDC 10 | 69539-124-01 |
| NDC Item | 69539012401 |
| packaging | 1 VIAL, GLASS in 1 BOX (69539-124-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS |
| ANDA | ANDA213049 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 456772 |
| Labeler | MSN LABORATORIES PRIVATE LIMITED |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-03-04 |
| Marketing status | ACTIVE |
NDC item 71288015710
| NDC 9 | 71288-157 |
|---|---|
| NDC 10 | 71288-157-10 |
| NDC Item | 71288015710 |
| packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-157-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
| ANDA | ANDA216037 |
| FDA SPL set id | 758393 |
| Labeler | Meitheal Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-12-26 |
| Marketing status | ACTIVE |
NDC item 72205004601
| NDC 9 | 72205-046 |
|---|---|
| NDC 10 | 72205-046-01 |
| NDC Item | 72205004601 |
| packaging | 1 VIAL, GLASS in 1 BOX (72205-046-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS |
| ANDA | ANDA213049 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 463379 |
| Labeler | Novadoz Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-02-01 |
| Marketing status | ACTIVE |